| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On November 13, 2007
|
|
|
|
|
|
|
|
|
|
|
| Docket
#
|
| Title
|
|
|
|
|
|
|
| 1978N-0038
|
| Sunscreen Drug Products
|
|
|
|
|
| 1986V-0315
|
| Ion laser technology series ILT 5000 Demo unit
|
|
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| 2005V-0054
|
| Laser Light Show
|
|
|
|
|
| 2006N-0221
|
| Requirements for Human Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use
|
|
|
|
|
| 2006P-0305
|
| Permit the Filing of an ANDA Suitability for Loperamide Hydrochloride Orally Dissolving Strips, 2 mg
|
|
|
|
|
| 2007N-0262
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine)
|
|
|
|
|
| 2007N-0321
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Evaluation of the Impact of Distraction on Consumer Understanding of Risk and Benefit Information in Direct
|
|
|
|
|
|
| 2007P-0448
|
| Petition Regarding Precose (Acarbose)
|
|
| |
|
| 1978N-0038
|
| Sunscreen Drug Products
|
|
|
|
|
| EREG 10
|
| S. Dobson
|
| Vol #:
|
| 163
|
|
|
|
|
| 1986V-0315
|
| Ion laser technology series ILT 5000 Demo unit
|
|
|
|
|
| VRA 10
|
| Lynne L. Rice
|
| Vol #:
|
| 1
|
|
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
| |
|
|
|
| C 765
|
| Kay Larson
|
| Vol #:
|
| 25
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| C 18339
|
| P. Morgan
|
| Vol #:
|
| 198
|
|
|
|
|
| 2005V-0054
|
| Laser Light Show
|
|
|
|
|
| VRA 1
|
| Lynne L. Rice
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006N-0221
|
| Requirements for Human Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use
|
|
|
|
|
| REF 1
|
| OMB Changes
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0305
|
| Permit the Filing of an ANDA Suitability for Loperamide Hydrochloride Orally Dissolving Strips, 2 mg
|
|
|
|
|
| WDL 1
|
| MonoSol Rx, LLC
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0262
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine)
|
|
|
|
|
| C 5
|
| Jeralyn Delaney
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0321
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Evaluation of the Impact of Distraction on Consumer Understanding of Risk and Benefit Information in Direct
|
|
|
|
|
|
|
|
|
| C 8
|
| Davidson & Company
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007P-0448
|
| Petition Regarding Precose (Acarbose)
|
|
